HCPCS code J9275 — Inj cosibelimab-ipdl, 2 mg. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

J9275

Active

Inj cosibelimab-ipdl, 2 mg

Injection, cosibelimab-ipdl, 2 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0915

MUE — Medically Unlikely Edits

Maximum units of J9275 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 600
Outpatient Hospital 600
Practitioner Services 600

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q3
    Inj cosibelimab-ipdl, 2 mg